Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'RECEPTOR ZETA-CHAIN' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 95 riferimenti
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Selliah, N; Finkel, TH
      Biochemical mechanisms of HIV induced T cell apoptosis

      CELL DEATH AND DIFFERENTIATION
    2. Park, D; Yun, Y
      Tyrosine phosphorylation-dependent yeast two-hybrid system for the identification of the SH2 domain-binding proteins

      MOLECULES AND CELLS
    3. Kunjibettu, S; Fuller-Espie, S; Carey, GB; Spain, LM
      Conserved transmembrane tyrosine residues of the TCR beta chain are required for TCR expression and function in primary T cells and hybridomas

      INTERNATIONAL IMMUNOLOGY
    4. Morley, SCP; Bierer, BE
      The actin cytoskeleton, membrane lipid microdomains, and T cell signal transduction

      ADVANCES IN IMMUNOLOGY, VOL 77
    5. Lagunoff, M; Lukac, DM; Ganem, D
      Immunoreceptor tyrosine-based activation motif-dependent signaling by Kaposi's sarcoma-associated herpesvirus K1 protein: Effects on lytic viral replication

      JOURNAL OF VIROLOGY
    6. Andersen, MH; Keikavoussi, P; Brocker, EB; Schuler-Thurner, B; Jonassen, M; Sondergaard, I; Straten, PT; Becker, JC; Kampgen, E
      Induction of systemic CTL responses in melanoma patients by dendritic cellvaccination: Cessation of CTL responses is associated with disease progression

      INTERNATIONAL JOURNAL OF CANCER
    7. Kono, K; Takahashi, A; Iizuka, H; Fujii, H; Sekikawa, T; Matsumoto, Y
      Effect of oesophagectomy on monocyte-induced apoptosis of peripheral bloodT lymphocytes

      BRITISH JOURNAL OF SURGERY
    8. Lieberman, J; Shankar, P; Manjunath, N; Andersson, J
      Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection

      BLOOD
    9. Krishnan, S; Warke, VG; Nambiar, MP; Wong, HK; Tsokos, GC; Farber, DL
      Generation and biochemical analysis of human effector CD4 T cells: alterations in tyrosine phosphorylation and loss of CD3 zeta expression

      BLOOD
    10. Radoja, S; Frey, AB
      Cancer-induced defective cytotoxic T lymphocyte effector function: Anothermechanism how antigenic tumors escape immune-mediated killing

      MOLECULAR MEDICINE
    11. Tsokos, GC; Wong, HK; Enyedy, EJ; Nambiar, MP
      Immune cell signaling in lupus

      CURRENT OPINION IN RHEUMATOLOGY
    12. Tamura, T; Kunimatsu, T; Yee, ST; Igarashi, O; Utsuyama, M; Tanaka, S; Miyazaki, S; Hirokawa, K; Nariuchi, H
      Molecular mechanism of the impairment in activation signal transduction inCD4(+) T cells from old mice

      INTERNATIONAL IMMUNOLOGY
    13. Fais, S; Luciani, F; Logozzi, M; Parlato, S; Lozupone, F
      Linkage between cell membrane proteins and actin-based cytoskeleton: the cytoskeletal-driven cellular functions

      HISTOLOGY AND HISTOPATHOLOGY
    14. Ilangumaran, S; He, HT; Hoessli, DC
      Microdomains in lymphocyte signalling: beyond GPI-anchored proteins

      IMMUNOLOGY TODAY
    15. Clavreul, A; Fisson, S; D'hellencourt, CL; Couez, D
      Interelationship between CD3 and CD28 pathways in a murine T cell thymoma

      MOLECULAR IMMUNOLOGY
    16. Farrar, MA; Olson, SH; Perlmutter, RM
      Coumermycin-induced dimerization of GyrB-containing fusion proteins

      APPLICATIONS OF CHIMERIC GENES AND HYBRID PROTEINS PT B
    17. Krummel, MF; Sjaastad, MD; Wulfing, C; Davis, MM
      Differential clustering of CD4 and CD3 zeta during T cell recognition

      SCIENCE
    18. Trimble, LA; Shankar, P; Patterson, M; Daily, JP; Lieberman, J
      Human immunodeficiency virus-specific circulating CD8 T lymphocytes have down-modulated CD3 zeta and CD28, key signaling molecules for T-cell activation

      JOURNAL OF VIROLOGY
    19. Kataoka, T; Yamada, A; Bando, M; Honma, T; Mizoue, K; Nagai, K
      FD-891, a structural analogue of concanamycin A that does not affect vacuolar acidification or perforin activity, yet potently prevents cytotoxic T lymphocyte-mediated cytotoxicity through the blockage of conjugate formation

      IMMUNOLOGY
    20. Chen, X; Woiciechowsky, A; Raffegerst, S; Schendel, D; Kolb, HJ; Roskrow, M
      Impaired expression of the CD3-zeta chain in peripheral blood T cells of patients with chronic myeloid leukaemia results in an increased susceptibility to apoptosis

      BRITISH JOURNAL OF HAEMATOLOGY
    21. Trimble, LA; Kam, LW; Friedman, RS; Xu, Z; Lieberman, J
      CD3 zeta and CD28 down-modulation on CD8 T cells during viral infection

      BLOOD
    22. Alvarez-Vallina, L
      Targeted cell immunotherapy of human cancer: a promising approach that is extending its initial cell and molecular scope

      TUMOR TARGETING
    23. Nolan, KF; Yun, CO; Akamatsu, Y; Murphy, JC; Leung, SO; Beecham, EJ; Junghans, RP
      Bypassing immunization: Optimized design of "designer T cells" against carcinoembryonic antigen (CEA)-expressing tumors, and lack of suppression by soluble CEA

      CLINICAL CANCER RESEARCH
    24. Bedenicki, I; Newton, DJ; Flanagan, BF; Johnson, PM; Rukavina, D; Christmas, SE
      Human decidualized endometrial T lymphocytes do not substantially down-regulate CD3 zeta

      AMERICAN JOURNAL OF REPRODUCTIVE IMMUNOLOGY
    25. Serrador, JM; Nieto, M; Sanchez-Madrid, F
      Cytoskeletal rearrangement during migration and activation of T lymphocytes

      TRENDS IN CELL BIOLOGY
    26. Reinhold, MI; Green, JM; Lindberg, FP; Ticchioni, M; Brown, EJ
      Cell spreading distinguishes the mechanism of augmentation of T cell activation by integrin-associated protein/CD47 and CD28

      INTERNATIONAL IMMUNOLOGY
    27. Gratama, JW; Zea, AH; Bolhuis, RLH; Ochoa, AC
      Restoration of expression of signal-transduction molecules in lymphocytes from patients with metastatic renal cell cancer after combination immunotherapy

      CANCER IMMUNOLOGY IMMUNOTHERAPY
    28. Tsokos, GC; Liossis, SNC
      Immune cell signaling defects in lupus: activation, anergy and death

      IMMUNOLOGY TODAY
    29. Kennedy, JS; Raab, M; Rudd, CE
      Signaling scaffolds in immune cells

      CELL CALCIUM
    30. Davis, MM; Wulfing, C; Krummel, MF; Savage, PA; Xu, J; Sumen, C; Dustin, ML; Chien, YH
      Visualizing T-cell recognition

      COLD SPRING HARBOR SYMPOSIA ON QUANTITATIVE BIOLOGY
    31. Kwon, ED; Foster, BA; Hurwitz, AA; Madias, C; Allison, JP; Greenberg, NM; Burg, MB
      Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy

      PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    32. Maccalli, C; Pisarra, P; Vegetti, C; Sensi, M; Parmiani, G; Anichini, A
      Differential loss of T cell signaling molecules in metastatic melanoma patients' T lymphocyte subsets expressing distinct TCR variable regions

      JOURNAL OF IMMUNOLOGY
    33. Zubiaur, M; Guirado, M; Terhorst, C; Malavasi, F; Sancho, J
      The CD3-gamma delta epsilon transducing module mediates CD38-induced protein-tyrosine kinase and mitogen-activated protein kinase activation in Jurkat T cells

      JOURNAL OF BIOLOGICAL CHEMISTRY
    34. ABO A
      UNDERSTANDING THE MOLECULAR-BASIS OF WISKOTT-ALDRICH-SYNDROME

      Cellular and molecular life sciences
    35. TOSELLO AC; MARY F; AMIOT M; BERNARD A; MARY D
      ACTIVATION OF T-CELLS VIA CD55 - RECRUITMENT OF EARLY COMPONENTS OF THE CD3-TCR PATHWAY IS REQUIRED FOR IL-2 SECRETION

      Journal of inflammation
    36. BUKOWSKI RM; RAYMAN P; UZZO R; BLOOM T; SANDSTROM K; PEEREBOOM D; OLENCKI T; BUDD GT; MCLAIN D; ELSON P; NOVICK A; FINKE JH
      SIGNAL-TRANSDUCTION ABNORMALITIES IN T-LYMPHOCYTES FROM PATIENTS WITHADVANCED RENAL-CARCINOMA - CLINICAL RELEVANCE AND EFFECTS OF CYTOKINETHERAPY

      Clinical cancer research
    37. XAVIER R; BRENNAN T; LI QQ; MCCORMACK C; SEED B
      MEMBRANE COMPARTMENTATION IS REQUIRED FOR EFFICIENT T-CELL ACTIVATION

      Immunity
    38. Moran, M; Miceli, MC
      Engagement of GPI-linked CD48 contributes to TCR signals and cytoskeletal reorganization: A role for lipid rafts in T cell activation

      IMMUNITY
    39. LINDAUER M; STANISLAWSKI T; HAUSSLER A; ANTUNES E; CELLARY A; HUBER C; THEOBALD M
      THE MOLECULAR-BASIS OF CANCER-IMMUNOTHERAPY BY CYTOTOXIC T-LYMPHOCYTES

      Journal of molecular medicine
    40. BISHARA A; AKER M; AMAR A; BRAUTBAR C; SCHLESINGER M; RABINOWITZ R; SLAVIN S; BANIYASH M
      ENHANCED LYMPHOID-CELL RECOVERY AFTER BONE-MARROW TRANSPLANTATION - CORRELATION WITH THE PRESENCE OF COSTIMULATORY ANTIBODIES IN SERUM

      Experimental hematology
    41. FITZERATTAS CJ; ESHHAR Z
      TYROSINE KINASE CHIMERAS FOR ANTIGEN-SELECTIVE T-BODY THERAPY

      Advanced drug delivery reviews
    42. ABKEN H; HOMBACH A; REINHOLD U; FERRONE S
      CAN COMBINED T-CELL-BASED AND ANTIBODY-BASED IMMUNOTHERAPY OUTSMART TUMOR-CELLS

      Immunology today
    43. VONBONIN A; HUHN J; FLEISCHER B
      DIPEPTIDYL-PEPTIDASE IV CD26 ON T-CELLS - ANALYSIS OF AN ALTERNATIVE T-CELL ACTIVATION PATHWAY/

      Immunological reviews
    44. STAVELEYOCARROLL K; SOTOMAYOR E; MONTGOMERY J; BORRELLO I; HWANG L; FEIN S; PARDOLL D; LEVITSKY H
      INDUCTION OF ANTIGEN-SPECIFIC T-CELL ANERGY - AN EARLY EVENT IN THE COURSE OF TUMOR PROGRESSION

      Proceedings of the National Academy of Sciences of the United Statesof America
    45. WOODSIDE DG; WOOTEN DK; MCINTYRE BW
      ADENOSINE-DIPHOSPHATE (ADP)-RIBOSYLATION OF THE GUANOSINE TRIPHOSPHATASE (GTPASE) RHO IN RESTING PERIPHERAL-BLOOD HUMAN T-LYMPHOCYTES RESULTS IN PSEUDOPODIAL EXTENSION AND THE INHIBITION OF T-CELL ACTIVATION

      The Journal of experimental medicine
    46. LOWINKROPF B; SHAPIRO VS; WEISS A
      CYTOSKELETAL POLARIZATION OF T-CELLS IS REGULATED BY AN IMMUNORECEPTOR TYROSINE-BASED ACTIVATION MOTIF-DEPENDENT MECHANISM

      The Journal of cell biology
    47. ZEITLMANN L; KNORR T; KNOLL M; ROMEO C; SIRIM P; KOLANUS W
      T-CELL ACTIVATION-INDUCED BY NOVEL GAIN-OF-FUNCTION MUTANTS OF SYK AND ZAP-70

      The Journal of biological chemistry
    48. ARNOULD T; KIM E; TSIOKAS L; JOCHIMSEN F; GRUNING W; CHANG JD; WALZ G
      THE POLYCYSTIC KIDNEY-DISEASE-1 GENE-PRODUCT MEDIATES PROTEIN-KINASE-C ALPHA-DEPENDENT AND C-JUN N-TERMINAL KINASE-DEPENDENT ACTIVATION OF THE TRANSCRIPTION FACTOR AP-1

      The Journal of biological chemistry
    49. ZEA AH; OCHOA MT; GHOSH P; LONGO DL; ALVORD WG; VALDERRAMA L; FALABELLA R; HARVEY LK; SARAVIA N; MORENO LH; OCHOA AC
      CHANGES IN EXPRESSION OF SIGNAL-TRANSDUCTION PROTEINS IN T-LYMPHOCYTES OF PATIENTS WITH LEPROSY

      Infection and immunity
    50. VONBONIN A; EHRLICH S; FLEISCHER B
      THE TRANSMEMBRANE REGION OF CD2-ASSOCIATED SIGNAL-TRANSDUCING PROTEINS IS CRUCIAL FOR THE OUTCOME OF CD2-MEDIATED T-CELL ACTIVATION

      Immunology
    51. Garcia, GG; Miller, RA
      Increased Zap-70 association with CD3 zeta in CD4 T cells from old mice

      CELLULAR IMMUNOLOGY
    52. BUGGINS AGS; HIRST WJR; PAGLIUCA A; MUFTI GJ
      VARIABLE EXPRESSION OF CD3-ZETA AND ASSOCIATED PROTEIN-TYROSINE KINASES IN LYMPHOCYTES FROM PATIENTS WITH MYELOID MALIGNANCIES

      British Journal of Haematology
    53. DEKONING J; KAYE JG
      REQUIREMENTS FOR DIFFERENTIATION OF AN IMMATURE CD4(-CELL LINE()8(+) T)

      Developmental immunology
    54. SCHARENBERG AM; KINET JP
      FC-EPSILON-RI AND THE FCR-BETA AMPLIFIER

      International archives of allergy and immunology
    55. BECKER JC; TERHEYDEN P; BROCKER EB
      MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN MELANOMA

      Melanoma research
    56. DAVE VP; CAO ZS; BROWNE C; ALARCON B; FERNANDEZMIGUEL G; LAFAILLE J; DELAHERA A; TONEGAWA S; KAPPES DJ
      CD3-DELTA DEFICIENCY ARRESTS DEVELOPMENT OF THE ALPHA-BETA BUT NOT THE GAMMA-DELTA T-CELL LINEAGE

      EMBO journal
    57. DALL P; HEKELE A; BECKMANN MW; BENDER HG; HERRLICH P; PONTA H
      EFFICIENT LYSIS OF CD44V7 8-PRESENTING TARGET-CELLS BY GENETICALLY-ENGINEERED CYTOTOXIC T-LYMPHOCYTES - A MODEL FOR IMMUNOGENE THERAPY OF CERVICAL-CANCER/

      Gynecologic oncology
    58. CORREA MR; OCHOA AC; GHOSH P; MIZOGUCHI H; HARVEY L; LONGO DL
      SEQUENTIAL DEVELOPMENT OF STRUCTURAL AND FUNCTIONAL ALTERATIONS IN T-CELLS FROM TUMOR-BEARING MICE

      The Journal of immunology
    59. SALVADORI S; ZIER K
      GENE-THERAPY WITH MODIFIED TUMOR-CELLS ENABLES T-CELL ACTIVATION BY STIMULATING PATHWAYS REQUIRED FOR SIGNAL-TRANSDUCTION

      Cytokines and molecular therapy
    60. TIAN H; LEMPICKI R; KING L; DONOGHUE E; SAMELSON LE; COHEN DI
      HIV ENVELOPE-DIRECTED SIGNALING ABERRANCIES AND CELL-DEATH OF CD4(-CELLS IN THE ABSENCE OF TCR CO-STIMULATION() T)

      International immunology
    61. KIESSLING R; KONO K; PETERSSON M; WASSERMAN K
      IMMUNOSUPPRESSION IN HUMAN TUMOR-HOST INTERACTION - ROLE OF CYTOKINESAND ALTERATIONS IN SIGNAL-TRANSDUCING MOLECULES

      Perspectives in mathematical logic
    62. LEVEY DL; SRIVASTAVA PK
      ALTERATIONS IN T-CELLS OF CANCER-BEARERS - WHENCE SPECIFICITY

      Immunology today
    63. SALVADORI S; ZIER K
      MOLECULAR-BASIS OF T-CELL DYSFUNCTION IN CANCER IS INFLUENCED BY THE PARACRINE SECRETION OF TUMOR-DERIVED IL-2

      The Journal of immunology
    64. WEISSENHORN W; ECK MJ; HARRISON SC; WILEY DC
      PHOSPHORYLATED T-CELL RECEPTOR XI-CHAIN AND ZAP70 TANDEM SH2 DOMAINS FORM A 1 3 COMPLEX IN-VITRO/

      European journal of biochemistry
    65. HULTEN MA; STACEY M; ARMSTRONG SJ
      DOES JUNK DNA REGULATE GENE-EXPRESSION IN HUMANS

      JCP. Clinical molecular pathology
    66. SHINKAI Y; MA A; CHENG HL; ALT FW
      CD3-EPSILON AND CD3-XI CYTOPLASMIC DOMAINS CAN INDEPENDENTLY GENERATESIGNALS FOR T-CELL DEVELOPMENT AND FUNCTION

      Immunity
    67. YANAGI S; KUROSAKI T; YAMAMURA H
      THE STRUCTURE AND FUNCTION OF NONRECEPTOR TYROSINE KINASE P72(SYK) EXPRESSED IN HEMATOPOIETIC-CELLS

      Cellular signalling
    68. HAUBER I; FISCHER MB; MARIS M; EIBL MM
      REDUCED IL-2 EXPRESSION UPON ANTIGEN STIMULATION IS ACCOMPANIED BY DEFICIENT IL-9 GENE-EXPRESSION IN T-CELLS OF PATIENTS WITH CVID

      Scandinavian journal of immunology
    69. ZENNER G; ZURHAUSEN JD; BURN P; MUSTELIN T
      TOWARDS UNRAVELING THE COMPLEXITY OF T-CELL SIGNAL-TRANSDUCTION

      BioEssays
    70. MIGITA K; EGUCHI K; KAWABE Y; TSUKADA T; ICHINOSE Y; NAGATAKI S
      DEFECTIVE TCR-MEDIATED SIGNALING IN ANERGIC T-CELLS

      The Journal of immunology
    71. STURMHOFEL K; BRANDO C; MARTINON F; SHEVACH EM; COLIGAN JE
      ANTIGEN-INDEPENDENT, INTEGRIN-MEDIATED T-CELL ACTIVATION

      The Journal of immunology
    72. TARTOUR E; LATOUR S; MATHIOT C; THIOUNN N; MOSSERI V; JOYEUX I; DENGHIEN CD; LEE RS; DEBRE B; FRIDMAN WH
      VARIABLE EXPRESSION OF CD3-ZETA CHAIN IN TUMOR-INFILTRATING LYMPHOCYTES (TIL) DERIVED FROM RENAL-CELL CARCINOMA - RELATIONSHIP WITH TIL PHENOTYPE AND FUNCTION

      International journal of cancer
    73. MATSUDA M; PETERSSON M; LENKEI R; TAUPIN JL; MAGNUSSON I; MELLSTEDT H; ANDERSON P; KIESSLING R
      ALTERATIONS IN THE SIGNAL-TRANSDUCING MOLECULES OF T-CELLS AND NK CELLS IN COLORECTAL TUMOR-INFILTRATING, GUT MUCOSAL AND PERIPHERAL LYMPHOCYTES - CORRELATION WITH THE STAGE OF THE DISEASE

      International journal of cancer
    74. BALDARI CT; DISOMMA MM; MILIA E; BERGMAN M; TELFORD JL
      INTERACTIONS BETWEEN THE TYROSINE KINASES P56LCK, P59FYN AND P50CSK IN CD4 SIGNALING IN T-CELLS

      European Journal of Immunology
    75. AOE T; GOTO S; OHNO H; SAITO T
      DIFFERENT CYTOPLASMIC STRUCTURE OF THE CD3-ZETA FAMILY DIMER MODULATES THE ACTIVATION SIGNAL AND FUNCTION OF T-CELLS

      International immunology
    76. TAKAI S; KASAMA M; YAMADA K; KAI N; HIRAYAMA N; NAMIKI H; TANIYAMA T
      HUMAN HIGH-AFFINITY FC-GAMMA-RI (CD64) GENE MAPPED TO CHROMOSOME 1Q21.2-Q21.3 BY FLUORESCENCE IN-SITU HYBRIDIZATION

      Human genetics
    77. RUDD CE; JANSSEN O; CAI YC; DASILVA AJ; RAAB M; PRASAD KVS
      2-STEP TCR-ZETA CD3-CD4 AND CD28 SIGNALING IN T-CELLS - SH2/SH3 DOMAINS, PROTEIN-TYROSINE AND LIPID KINASES/

      Immunology today
    78. KOYASU S; TSE AGD; MOINGEON P; HUSSEY RE; MILDONIAN A; HANNISIAN J; CLAYTON LK; REINHERZ EL
      DELINEATION OF A T-CELL ACTIVATION MOTIF REQUIRED FOR BINDING OF PROTEIN-TYROSINE KINASES CONTAINING TANDEM SH2 DOMAINS

      Proceedings of the National Academy of Sciences of the United Statesof America
    79. MORITZ D; WELS W; MATTERN J; GRONER B
      CYTOTOXIC T-LYMPHOCYTES WITH A GRAFTED RECOGNITION SPECIFICITY FOR ERBB2-EXPRESSING TUMOR-CELLS

      Proceedings of the National Academy of Sciences of the United Statesof America
    80. ORCHANSKY PL; TEH HS
      ACTIVATION-INDUCED CELL-DEATH IN PROLIFERATING T-CELLS IS ASSOCIATED WITH ALTERED TYROSINE PHOSPHORYLATION OF TCR CD3 SUBUNITS/

      The Journal of immunology
    81. SALVADORI S; GANSBACHER B; PIZZIMENTI AM; ZIER KS
      ABNORMAL SIGNAL-TRANSDUCTION BY T-CELLS OF MICE WITH PARENTAL TUMORS IS NOT SEEN IN MICE BEARING IL-2-SECRETING TUMORS

      The Journal of immunology
    82. VANOERS NSC; TEH SJ; IRVING BA; TIONG J; WEISS A; TEH HS
      PRODUCTION AND CHARACTERIZATION OF MONOCLONAL-ANTIBODIES SPECIFIC FORTHE MURINE T-CELL RECEPTOR ZETA-CHAIN

      Journal of immunological methods
    83. KOYASU S
      CD3(-BETA-TCR(+)CD4(-)CD8(-) AND GAMMA-DELTA-TCR(+)CD4(-)CD8(-) CELLS()CD16(+)NK1.1(+)B220(+) LARGE GRANULAR LYMPHOCYTES ARISE FROM BOTH ALPHA)

      The Journal of experimental medicine
    84. KANAKARAJ P; DUCKWORTH B; AZZONI L; KAMOUN M; CANTLEY LC; PERUSSIA B
      PHOSPHATIDYLINOSITOL-3 KINASE ACTIVATION-INDUCED UPON FC-GAMMA-RIIIA-LIGAND INTERACTION

      The Journal of experimental medicine
    85. CHU KT; LITTMAN DR
      REQUIREMENT FOR KINASE-ACTIVITY OF CD4-ASSOCIATED P56(LCK) IN ANTIBODY-TRIGGERED T-CELL SIGNAL-TRANSDUCTION

      The Journal of biological chemistry
    86. EGERTON M; SAMELSON LE
      BIOCHEMICAL-CHARACTERIZATION OF VALOSIN-CONTAINING PROTEIN, A PROTEIN-TYROSINE KINASE SUBSTRATE IN HEMATOPOIETIC-CELLS

      The Journal of biological chemistry
    87. AOE T; OHNO H; SONTA S; SAITO T
      FUNCTIONAL INACTIVATION OF THE CD3-ZETA CHAIN IN A T-CELL HYBRIDOMA BY IN-VITRO GENE TARGETING

      International immunology
    88. LIU CP; UEDA R; SHE JA; SANCHO J; WANG BP; WEDDELL G; LORING J; KURAHARA C; DUDLEY EC; HAYDAY A; TERHORST C; HUANG M
      ABNORMAL T-CELL DEVELOPMENT IN CD3-ZETA- - MUTANT MICE AND IDENTIFICATION OF A NOVEL T-CELL POPULATION IN THE INTESTINE/

      EMBO journal
    89. OHNO H; AOE T; TAKI S; KITAMURA D; ISHIDA Y; RAJEWSKY K; SAITO T
      DEVELOPMENTAL AND FUNCTIONAL IMPAIRMENT OF T-CELLS IN MICE LACKING CD3-ZETA CHAINS

      EMBO journal
    90. XU H; LITTMAN DR
      A KINASE-INDEPENDENT FUNCTION OF LCK IN POTENTIATING ANTIGEN-SPECIFICT-CELL ACTIVATION

      Cell
    91. KOLANUS W; ROMEO C; SEED B
      T-CELL ACTIVATION BY CLUSTERED TYROSINE KINASES

      Cell
    92. MOLINA TJ; BACHMANN MF; KUNDIG TM; ZINKERNAGEL RM; MAK TW
      PERIPHERAL T-CELLS IN MICE LACKING P56(LCK) DO NOT EXPRESS SIGNIFICANT ANTIVIRAL EFFECTOR FUNCTIONS

      The Journal of immunology
    93. HUBERT P; DEBRE P; BOUMSELL L; BISMUTH G
      TYROSINE PHOSPHORYLATION AND ASSOCIATION WITH PHOSPHOLIPASE-C-GAMMA-11 OF THE GAP-ASSOCIATED 62-KD PROTEIN AFTER CD2 STIMULATION OF JURKATT-CELL

      The Journal of experimental medicine
    94. VIVIER E; DASILVA AJ; ACKERLY M; LEVINE H; RUDD CE; ANDERSON P
      ASSOCIATION OF A 70-KDA TYROSINE PHOSPHOPROTEIN WITH THE CD16-ZETA-GAMMA COMPLEX EXPRESSED IN HUMAN NATURAL-KILLER-CELLS

      European Journal of Immunology
    95. RINCON M; TUGORES A; DELANDAZURI MO; LOPEZBOTET M
      COSTIMULATION OF CAMP AND PROTEIN-KINASE-C PATHWAYS INHIBITS THE CD3-DEPENDENT T-CELL ACTIVATION AND LEADS TO A PERSISTENT EXPRESSION OF THE AP-1 TRANSCRIPTION FACTOR

      Cellular immunology


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 21/01/21 alle ore 03:49:21